Annual report
160A.TEDINET S100YIQV
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 90
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥17.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥17.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.8bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.6bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥866m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥298m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.6bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥957m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥564m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥230m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥485m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥24.4bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥21.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥16.0bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥19.2bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥17.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.2bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2023-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.9bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥745m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥339m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥708m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥928m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥599m | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥884m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥369m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥330.9 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥269.74 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.81 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥171.95 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥327.52 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.57 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥70 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥38 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,440.46 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,164.14 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥785.49 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥615.49 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥555.68 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 21.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 25.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 29.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 35.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,587,400 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,576,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,030,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 985 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 879 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 811 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 721 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 680 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 55
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥131m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥131m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥1.9bn |
| Nursing Care And Senior Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥229m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥83m |
| Nursing Care And Senior Businessreportable segment | employees | at 2026-03-31 | 898 pure |
| Nursing Care And Senior Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2026-03-31 | ¥9.3bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Real Estate Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Real Estate Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥113m |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 12 pure |
| Real Estate Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| Real Estate Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8.2bn |
| Real Estate Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥131m |
| Real Estate Businessreportable segment | segment assets | at 2026-03-31 | ¥12.5bn |
| Real Estate Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥5.2bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥196m |
| —segment total | employees | at 2026-03-31 | 910 pure |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥23.8bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥23.7bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥131m |
| —segment total | segment assets | at 2026-03-31 | ¥21.8bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥3.4bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Nursing Care And Senior Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥74m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥61m |
| Nursing Care And Senior Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2025-03-31 | ¥8.1bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| Real Estate Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥133m |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.2bn |
| Real Estate Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| Real Estate Businessreportable segment | segment assets | at 2025-03-31 | ¥10.5bn |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥195m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥18.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥17.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| —segment total | segment assets | at 2025-03-31 | ¥18.6bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 985
| Item | Context | Value | Unit |
|---|---|---|---|
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | Original text (Japanese)森脇 仁子 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | 1964-09-24 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | Original text (Japanese)(注)４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | Original text (Japanese)塩生 朋子 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | 1975-06-20 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | Original text (Japanese)(注)４ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYearDuration | Original text (Japanese)当社は子会社がありませんので、連結財務諸表を作成しておりません。 | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes additional information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding financial covenant (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |